Share of one year olds who received the final dose of pneumococcal in Nigeria
Nigeria: Share of one year olds who received the final dose of pneumococcal was 62 in 2025. ▲ Rising
Latest (2025)
62
Change on year
down 1.6%
World rank
138th
of 154 countries
All-time high
64
in 2019
All-time low
36
in 2015
Years of data
11
2015–2025
Share of one year olds who received the final dose of pneumococcal in Nigeria, 2015–2025
Source: Our World in Data.
Analysis
Nigeria recorded 62 for share of one year olds who received the final dose of pneumococcal in 2025.
Compared with earlier readings it is down 1.6% on the previous year and up 72.2% over ten years.
Over the whole period, share of one year olds who received the final dose of pneumococcal in Nigeria peaked at 64 in 2019 and was at its lowest, 36, in 2015.
Nigeria ranks 138th of 154 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 11 years of available data.
Share of one year olds who received the final dose of pneumococcal in Nigeria, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 36 | — |
| 2016 | 49 | +36.1% |
| 2017 | 53 | +8.2% |
| 2018 | 59 | +11.3% |
| 2019 | 64 | +8.5% |
| 2020 | 60 | -6.2% |
| 2021 | 48 | -20.0% |
| 2022 | 56 | +16.7% |
| 2023 | 62 | +10.7% |
| 2024 | 63 | +1.6% |
| 2025 | 62 | -1.6% |
Nigeria compared with similar countries
- Nigeria's 62 is below the median for lower middle income countries, which is 85.5, 73% of the median. (42 countries reporting)
- Nigeria's 62 is below the median for Sub-Saharan Africa, which is 86.5, 72% of the median. (40 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 52.2 | 36 | 64 | 5 |
| 2020s | 58.5 | 48 | 63 | 6 |
Countries ranked near Nigeria
- 135 Benin 64 compare
- 136 Afghanistan 63 compare
- 136 Democratic Republic of Congo 63 compare
- 138 Laos 62 compare
- 138 Marshall Islands 62 compare
- 141 North Macedonia 60 compare
More health data for Nigeria
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8137 % change on previous year (2090)
- Un projection of annual infant deaths 257,921 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 14 (2025)
- Population ages 00-04, female, annual growth rate 1.14 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0711 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.17 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0729 units per person (2025)
Frequently asked questions
- What is share of one year olds who received the final dose of pneumococcal in Nigeria?
- Share of one year olds who received the final dose of pneumococcal in Nigeria was 62 in 2025, according to Our World in Data.
- What is the highest share of one year olds who received the final dose of pneumococcal recorded in Nigeria?
- The highest recorded value was 64 in 2019.
- What is the lowest share of one year olds who received the final dose of pneumococcal recorded in Nigeria?
- The lowest recorded value was 36 in 2015.
- How does Nigeria rank for share of one year olds who received the final dose of pneumococcal?
- Nigeria ranks 138th out of 154 countries with data for 2025.
- Is share of one year olds who received the final dose of pneumococcal rising or falling in Nigeria?
- Over the last ten years it is up 72.2%. The long-run trend across the full record is rising.
- Where does this Nigeria data come from?
- The figures come from Our World in Data, published as part of Share of one year olds who received the final dose of pneumococcal vaccine. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY 4.0 (Our World in Data).